Endoprosthesis market experiencing rapid growth, fueled by aging population and surgical advancements.

From GlobeNewswire: 2024-12-02 08:00:00

The Endoprosthesis Market was valued at USD 25.94 billion in 2023 and is projected to reach USD 60.39 billion by 2032, with a CAGR of 9.86% from 2024 to 2032. Endoprostheses are used for joint and bone replacement, driven by an aging population and advancements in surgical procedures and materials.

Key market players include Johnson & Johnson, Zimmer Biomet, and Stryker, catering to the increasing demand for endoprostheses. The market is rapidly growing in regions like North America, Europe, and Asia, fueled by rising awareness of joint health and access to surgical treatments.

In 2023, knee reconstruction endoprostheses dominated the market with 35% share, driven by common knee-related conditions and advancements in prosthetic materials. Metallic materials like titanium and cobalt-chromium alloys held 40% market share, favored for their durability and biocompatibility.

The Endoprosthesis Market is witnessing significant growth in key regions such as North America, Europe, and Asia-Pacific, with North America leading due to advanced healthcare infrastructure and high joint replacement surgeries. Recent developments include clinical trials and product launches to enhance endovascular treatment options. Advancements in prosthetic materials and surgical techniques will improve patient outcomes, with increased healthcare access driving market growth. Product launches and clinical trials showcase ongoing innovations in the endoprosthesis field. SNS Insider offers a Single-User PDF of Endoprosthesis Market Analysis & Outlook Report 2024-2032 for purchase, providing valuable market insights for decision-making.



Read more at GlobeNewswire: Endoprosthesis Market Size to Surpass USD 60.39 Billion by